IBDEI1TX ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,29227,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29227,1,3,0)
;;=3^Medication-Induced Parkinsonism,Other
;;^UTILITY(U,$J,358.3,29227,1,4,0)
;;=4^G21.19
;;^UTILITY(U,$J,358.3,29227,2)
;;=^5003773
;;^UTILITY(U,$J,358.3,29228,0)
;;=G21.11^^118^1471^13
;;^UTILITY(U,$J,358.3,29228,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29228,1,3,0)
;;=3^Neuroleptic-Induced Parkinsonism
;;^UTILITY(U,$J,358.3,29228,1,4,0)
;;=4^G21.11
;;^UTILITY(U,$J,358.3,29228,2)
;;=^5003772
;;^UTILITY(U,$J,358.3,29229,0)
;;=G24.01^^118^1471^15
;;^UTILITY(U,$J,358.3,29229,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29229,1,3,0)
;;=3^Tardive Dyskinesia
;;^UTILITY(U,$J,358.3,29229,1,4,0)
;;=4^G24.01
;;^UTILITY(U,$J,358.3,29229,2)
;;=^5003784
;;^UTILITY(U,$J,358.3,29230,0)
;;=G24.09^^118^1471^16
;;^UTILITY(U,$J,358.3,29230,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29230,1,3,0)
;;=3^Tardive Dystonia
;;^UTILITY(U,$J,358.3,29230,1,4,0)
;;=4^G24.09
;;^UTILITY(U,$J,358.3,29230,2)
;;=^5003786
;;^UTILITY(U,$J,358.3,29231,0)
;;=G25.1^^118^1471^11
;;^UTILITY(U,$J,358.3,29231,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29231,1,3,0)
;;=3^Medication-Induced Postural Tremor
;;^UTILITY(U,$J,358.3,29231,1,4,0)
;;=4^G25.1
;;^UTILITY(U,$J,358.3,29231,2)
;;=^5003792
;;^UTILITY(U,$J,358.3,29232,0)
;;=G25.71^^118^1471^14
;;^UTILITY(U,$J,358.3,29232,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29232,1,3,0)
;;=3^Tardive Akathisia
;;^UTILITY(U,$J,358.3,29232,1,4,0)
;;=4^G25.71
;;^UTILITY(U,$J,358.3,29232,2)
;;=^5003799
;;^UTILITY(U,$J,358.3,29233,0)
;;=G25.79^^118^1471^9
;;^UTILITY(U,$J,358.3,29233,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29233,1,3,0)
;;=3^Medication-Induced Movement Disorder,Other
;;^UTILITY(U,$J,358.3,29233,1,4,0)
;;=4^G25.79
;;^UTILITY(U,$J,358.3,29233,2)
;;=^5003800
;;^UTILITY(U,$J,358.3,29234,0)
;;=T43.205A^^118^1471^4
;;^UTILITY(U,$J,358.3,29234,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29234,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
;;^UTILITY(U,$J,358.3,29234,1,4,0)
;;=4^T43.205A
;;^UTILITY(U,$J,358.3,29234,2)
;;=^5050540
;;^UTILITY(U,$J,358.3,29235,0)
;;=T43.205D^^118^1471^5
;;^UTILITY(U,$J,358.3,29235,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29235,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
;;^UTILITY(U,$J,358.3,29235,1,4,0)
;;=4^T43.205D
;;^UTILITY(U,$J,358.3,29235,2)
;;=^5050541
;;^UTILITY(U,$J,358.3,29236,0)
;;=T43.205S^^118^1471^6
;;^UTILITY(U,$J,358.3,29236,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29236,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Sequela
;;^UTILITY(U,$J,358.3,29236,1,4,0)
;;=4^T43.205S
;;^UTILITY(U,$J,358.3,29236,2)
;;=^5050542
;;^UTILITY(U,$J,358.3,29237,0)
;;=G25.71^^118^1471^7
;;^UTILITY(U,$J,358.3,29237,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29237,1,3,0)
;;=3^Medication-Induced Acute Akathisia
;;^UTILITY(U,$J,358.3,29237,1,4,0)
;;=4^G25.71
;;^UTILITY(U,$J,358.3,29237,2)
;;=^5003799
;;^UTILITY(U,$J,358.3,29238,0)
;;=G24.02^^118^1471^8
;;^UTILITY(U,$J,358.3,29238,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29238,1,3,0)
;;=3^Medication-Induced Acute Dystonia
;;^UTILITY(U,$J,358.3,29238,1,4,0)
;;=4^G24.02
;;^UTILITY(U,$J,358.3,29238,2)
;;=^5003785
;;^UTILITY(U,$J,358.3,29239,0)
;;=G21.0^^118^1471^12
;;^UTILITY(U,$J,358.3,29239,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1TX 3787 printed Sep 23, 2025@19:51:44 Page 2
IBDEI1TX ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,29227,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,29227,1,3,0)
+4 ;;=3^Medication-Induced Parkinsonism,Other
+5 ;;^UTILITY(U,$J,358.3,29227,1,4,0)
+6 ;;=4^G21.19
+7 ;;^UTILITY(U,$J,358.3,29227,2)
+8 ;;=^5003773
+9 ;;^UTILITY(U,$J,358.3,29228,0)
+10 ;;=G21.11^^118^1471^13
+11 ;;^UTILITY(U,$J,358.3,29228,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,29228,1,3,0)
+14 ;;=3^Neuroleptic-Induced Parkinsonism
+15 ;;^UTILITY(U,$J,358.3,29228,1,4,0)
+16 ;;=4^G21.11
+17 ;;^UTILITY(U,$J,358.3,29228,2)
+18 ;;=^5003772
+19 ;;^UTILITY(U,$J,358.3,29229,0)
+20 ;;=G24.01^^118^1471^15
+21 ;;^UTILITY(U,$J,358.3,29229,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,29229,1,3,0)
+24 ;;=3^Tardive Dyskinesia
+25 ;;^UTILITY(U,$J,358.3,29229,1,4,0)
+26 ;;=4^G24.01
+27 ;;^UTILITY(U,$J,358.3,29229,2)
+28 ;;=^5003784
+29 ;;^UTILITY(U,$J,358.3,29230,0)
+30 ;;=G24.09^^118^1471^16
+31 ;;^UTILITY(U,$J,358.3,29230,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,29230,1,3,0)
+34 ;;=3^Tardive Dystonia
+35 ;;^UTILITY(U,$J,358.3,29230,1,4,0)
+36 ;;=4^G24.09
+37 ;;^UTILITY(U,$J,358.3,29230,2)
+38 ;;=^5003786
+39 ;;^UTILITY(U,$J,358.3,29231,0)
+40 ;;=G25.1^^118^1471^11
+41 ;;^UTILITY(U,$J,358.3,29231,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,29231,1,3,0)
+44 ;;=3^Medication-Induced Postural Tremor
+45 ;;^UTILITY(U,$J,358.3,29231,1,4,0)
+46 ;;=4^G25.1
+47 ;;^UTILITY(U,$J,358.3,29231,2)
+48 ;;=^5003792
+49 ;;^UTILITY(U,$J,358.3,29232,0)
+50 ;;=G25.71^^118^1471^14
+51 ;;^UTILITY(U,$J,358.3,29232,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,29232,1,3,0)
+54 ;;=3^Tardive Akathisia
+55 ;;^UTILITY(U,$J,358.3,29232,1,4,0)
+56 ;;=4^G25.71
+57 ;;^UTILITY(U,$J,358.3,29232,2)
+58 ;;=^5003799
+59 ;;^UTILITY(U,$J,358.3,29233,0)
+60 ;;=G25.79^^118^1471^9
+61 ;;^UTILITY(U,$J,358.3,29233,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,29233,1,3,0)
+64 ;;=3^Medication-Induced Movement Disorder,Other
+65 ;;^UTILITY(U,$J,358.3,29233,1,4,0)
+66 ;;=4^G25.79
+67 ;;^UTILITY(U,$J,358.3,29233,2)
+68 ;;=^5003800
+69 ;;^UTILITY(U,$J,358.3,29234,0)
+70 ;;=T43.205A^^118^1471^4
+71 ;;^UTILITY(U,$J,358.3,29234,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,29234,1,3,0)
+74 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
+75 ;;^UTILITY(U,$J,358.3,29234,1,4,0)
+76 ;;=4^T43.205A
+77 ;;^UTILITY(U,$J,358.3,29234,2)
+78 ;;=^5050540
+79 ;;^UTILITY(U,$J,358.3,29235,0)
+80 ;;=T43.205D^^118^1471^5
+81 ;;^UTILITY(U,$J,358.3,29235,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,29235,1,3,0)
+84 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
+85 ;;^UTILITY(U,$J,358.3,29235,1,4,0)
+86 ;;=4^T43.205D
+87 ;;^UTILITY(U,$J,358.3,29235,2)
+88 ;;=^5050541
+89 ;;^UTILITY(U,$J,358.3,29236,0)
+90 ;;=T43.205S^^118^1471^6
+91 ;;^UTILITY(U,$J,358.3,29236,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,29236,1,3,0)
+94 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
+95 ;;^UTILITY(U,$J,358.3,29236,1,4,0)
+96 ;;=4^T43.205S
+97 ;;^UTILITY(U,$J,358.3,29236,2)
+98 ;;=^5050542
+99 ;;^UTILITY(U,$J,358.3,29237,0)
+100 ;;=G25.71^^118^1471^7
+101 ;;^UTILITY(U,$J,358.3,29237,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,29237,1,3,0)
+104 ;;=3^Medication-Induced Acute Akathisia
+105 ;;^UTILITY(U,$J,358.3,29237,1,4,0)
+106 ;;=4^G25.71
+107 ;;^UTILITY(U,$J,358.3,29237,2)
+108 ;;=^5003799
+109 ;;^UTILITY(U,$J,358.3,29238,0)
+110 ;;=G24.02^^118^1471^8
+111 ;;^UTILITY(U,$J,358.3,29238,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,29238,1,3,0)
+114 ;;=3^Medication-Induced Acute Dystonia
+115 ;;^UTILITY(U,$J,358.3,29238,1,4,0)
+116 ;;=4^G24.02
+117 ;;^UTILITY(U,$J,358.3,29238,2)
+118 ;;=^5003785
+119 ;;^UTILITY(U,$J,358.3,29239,0)
+120 ;;=G21.0^^118^1471^12
+121 ;;^UTILITY(U,$J,358.3,29239,1,0)
+122 ;;=^358.31IA^4^2
